Conference Details Date: December 4, 2025 Location: New York, New York Format: 1x1 meetings (contact your Benchmark Representative) ...

For more information about Syncromune®, Inc. please visit www.syncromune.com.

While the vast majority of Black and African American 23andMe Research Institute members on the latest genotyping chip will receive one or more of these new groups, there is more work to do. The ...

Mr. Rubin will lead and oversee Nasus Pharma’s financial operations, including corporate finance, financial planning, capital strategy, and investor relations, as the Company advances its pipeline of ...

Archived copies of the webcast will be available for up to one year on the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.

Conference: Evercore ISI 8 th Annual HealthCONx Conference Format: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4) Presenter: Taylor Schreiber, M.D., Ph.D., ...

This novel, low-dose advancement in digital X-ray enables visualization of anatomy in motion with a simple acquisition. The seven RSNA 2025 presentations further demonstrate the clinical value of DDR ...

A link to the live and archived webcast for the Piper Sandler conference may be accessed on Opus Genetics’ website under the Investors section: Events.

FibroBiologics is conducting a prospective, multicenter, randomized clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to ...

A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available after the event and archived on the website ...

Now in its 31st year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public ...

We’re excited to present a review of our robust data package at OIS, highlighting our momentum toward advancing this innovation into clinical evaluation.” About VLTR-559 VLTR-559 is a long-acting anti ...